Pernix Ireland, a wholly owned subsidiary of Pernix Therapeutics has signed a definitive agreement to acquire the Zohydro ER franchise from Zogenix Read the full story

Arrowhead Research announced the acquisition of Novartis' entire RNAi research and development portfolio and associated assets Read the full story

Boston Scientific will acquire Endo's American Medical Systems' (AMS) Men's and Prostate Health businesses for up to $1.65 billion Read the full story

GlaxoSmithKline and Sun Pharmaceutical have reached an agreement related to GSK’s Opiates business in Australia Read the full story

Big pharma giant Johnson & Johnson has found a buyer for its Cordis unit, a manufacturer of cardiology and endovascular devices, which it put on the market in August 2014 . Read the full story

Endo International is selling its men’s health and prostate urology businesses to Boston Scientific Corp. for $1.6 billion, as it attempts to refocus its efforts on more lucrative parts of its portfolio and regain revenue after a rocky 2014. Read the full story

Actavis has entered into an agreement with Mayne Pharma, under which it will divest the U.S. rights to the Doryx Read the full story

Evolva Holding announced that Emergent BioSolutions has acquired Evolva’s anti-bacterial programme, the EV-035 series Read the full story

AbbVie has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site in Singapore's Tuas Biomedical Park Read the full story